alvameline
Sign in to saveAlvameline (Lu 25-109) is a M1 receptor agonist and M2/M3 receptor antagonist that was under investigation for the treatment of Alzheimer's disease, but produced poor results in clinical trials and was subsequently discontinued.
~1 min read
Encyclopedic overview
2 sectionsContents
- See also
- References
Alvameline (Lu 25-109) is a M1 receptor agonist and M2/M3 receptor antagonist that was under investigation for the treatment of Alzheimer's disease, but produced poor results in clinical trials and was subsequently discontinued.
== See also == Milameline Sabcomeline Tazomeline Xanomeline
Excerpted from Wikipedia’s “alvameline” article, available under the CC BY-SA 4.0 licence.